Many of us were excited to hear CMS was changing the requirements for Medicare patients to qualify for a continuous glucose monitor during Covid times. Unfortunately, the adjustments weren’t as significant as we were hoping. Here is an update on how the CGM companies and distributors are interpreting the new guidelines:
- Telehealth video appointments are now accepted
- Medicare is paying the provider the same rate for a telehealth appointment as they would an in-person appointments
- Patients who have tested positive for Covid-19 do not have to meet the requirements (4+ BG/day and 3+ injections/day or a pump) to receive a Dexcom. However, to continue with their Dexcom supplies in the future, they will need to meet the current Medicare criteria.
Katy Hawkins, RD, LDN, CDCES